New Therapy Option for Congenital Thrombotic Thrombocytopenic Purpura

Letter/Communication

Anjali Sharathkumar

NEJM journal watch. Oncology & hematology

05/21/2024

View Online

Recombinant ADAMTS13 shows promise both as an on-demand and a prophylaxis regimen.

Disease Prevention

Patient Safety

Medical research

Purpura

Title: Subtitle: New Therapy Option for Congenital Thrombotic Thrombocytopenic Purpura
Creators: Anjali Sharathkumar
Resource Type: Letter/Communication
Publication Details: NEJM journal watch. Oncology & hematology
Publisher: Massachusetts Medical Society
ISSN: 2330-0426
Language: English
Date published: 05/21/2024
Academic Unit: Stead Family Department of Pediatrics; Hematology/Oncology
Record Identifier: 9984628051102771

5 Record Views